Globus Medical (GMED) Current Deferred Revenue (2017 - 2026)

Globus Medical has reported Current Deferred Revenue for 10 years, with the latest figure at $34.9 million in Q1 2026.

• For the quarter ending Q1 2026, Current Deferred Revenue rose 103.22% year-over-year to $34.9 million; the trailing twelve-month figure through Mar 2026 stood at $34.9 million (up 103.22% YoY), and the FY2025 full-year result was $36.9 million, up 66.67% from the prior year.
• Current Deferred Revenue for Q1 2026 stood at $34.9 million, down from $36.9 million in the prior quarter.
• The five-year high for Current Deferred Revenue was $36.9 million in Q4 2025, with the low at $11.8 million in Q1 2022.
• Historically, Current Deferred Revenue has averaged $19.3 million across 5 years, with a median of $18.0 million in 2023.
• Annual changes were most pronounced in 2025 — Current Deferred Revenue retreated 12.19% — and 2026, when it surged 103.22%.
• Globus Medical's Current Deferred Revenue stood at $14.1 million in 2022, then jumped by 30.28% to $18.4 million in 2023, then advanced by 20.53% to $22.1 million in 2024, then soared by 66.67% to $36.9 million in 2025, then slipped by 5.43% to $34.9 million in 2026.
• The last three Current Deferred Revenue figures came in at $34.9 million (Q1 2026), $36.9 million (Q4 2025), and $18.3 million (Q3 2025), per Business Quant data.